Waters Parkerson & Co’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,783
Closed -$3.95M 173
2022
Q3
$3.95M Sell
37,783
-86,932
-70% -$9.54M 0.26% 56
2022
Q2
$13.1M Sell
124,715
-6,363
-5% -$755K 0.83% 46
2022
Q1
$16.8M Sell
131,078
-4,450
-3% -$536K 0.94% 44
2021
Q4
$16.7M Buy
135,528
+4,249
+3% +$556K 0.88% 44
2021
Q3
$18.7M Buy
131,279
+10,197
+8% +$1.5M 1.07% 39
2021
Q2
$18.9M Buy
121,082
+1,493
+1% +$242K 1.09% 37
2021
Q1
$18.6M Buy
119,589
+958
+0.8% +$148K 1.15% 36
2020
Q4
$17.7M Buy
118,631
+870
+0.7% +$123K 1.19% 32
2020
Q3
$15.6M Sell
117,761
-882
-0.7% -$115K 1.17% 32
2020
Q2
$13.7M Buy
118,643
+1,468
+1% +$169K 1.12% 33
2020
Q1
$11.5M Buy
117,175
+12,448
+12% +$1.63M 1.12% 35
2019
Q4
$15.2M Buy
104,727
+327
+0.3% +$45.1K 1.14% 33
2019
Q3
$13.9M Buy
104,400
+179
+0.2% +$23.1K 1.12% 35
2019
Q2
$11.9M Buy
104,221
+4,234
+4% +$496K 0.97% 40
2019
Q1
$12.4M Buy
99,987
+9,218
+10% +$1.05M 1.04% 36
2018
Q4
$9.14M Buy
90,769
+12,381
+16% +$1.39M 0.88% 39
2018
Q3
$10M Buy
78,388
+22,737
+41% +$2.7M 0.82% 44
2018
Q2
$6.02M Buy
+55,651
New +$6.06M 0.52% 49

Other funds holding ZBH

Waters Parkerson & Co's ZBH Position: Q4 2022 in Review

Waters Parkerson & Co sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 37,783 shares — an estimated $3.95M sold.

Waters Parkerson & Co first reported a position in ZBH in Q2 2018 and held it in 18 quarters. The position peaked at $18.9M in Q2 2021. 978 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Waters Parkerson & Co reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
  • Waters Parkerson & Co sold 37,783 Zimmer Biomet shares in Q4 2022, an estimated $3.95M.
  • Waters Parkerson & Co first reported a position in Zimmer Biomet in Q2 2018 and held it in 18 quarters.
  • Waters Parkerson & Co's Zimmer Biomet position peaked at $18.9M in Q2 2021.
  • 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Waters Parkerson & Co's 13F filing for Q4 2022, filed 10 Feb 2023.